SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-021507
Filing Date
2023-05-12
Accepted
2023-05-12 08:05:25
Documents
66
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q inab-20230331.htm   iXBRL 10-Q 1940166
2 EX-31.1 inab-ex31_1.htm EX-31.1 24859
3 EX-31.2 inab-ex31_2.htm EX-31.2 23939
4 EX-32.1 inab-ex32_1.htm EX-32.1 23055
5 GRAPHIC img238861063_0.jpg GRAPHIC 126550
  Complete submission text file 0000950170-23-021507.txt   6993845

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT inab-20230331_cal.xml EX-101.CAL 43091
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT inab-20230331_lab.xml EX-101.LAB 401853
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT inab-20230331.xsd EX-101.SCH 47581
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT inab-20230331_pre.xml EX-101.PRE 310561
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT inab-20230331_def.xml EX-101.DEF 144966
60 EXTRACTED XBRL INSTANCE DOCUMENT inab-20230331_htm.xml XML 997938
Mailing Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118
Business Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118 (646) 600-6438
IN8BIO, INC. (Filer) CIK: 0001740279 (see all company filings)

IRS No.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39692 | Film No.: 23913234
SIC: 2836 Biological Products, (No Diagnostic Substances)